Thrombogenicity
WikiDoc Resources for Thrombogenicity |
Articles |
---|
Most recent articles on Thrombogenicity Most cited articles on Thrombogenicity |
Media |
Powerpoint slides on Thrombogenicity |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Thrombogenicity at Clinical Trials.gov Trial results on Thrombogenicity Clinical Trials on Thrombogenicity at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Thrombogenicity NICE Guidance on Thrombogenicity
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Thrombogenicity Discussion groups on Thrombogenicity Patient Handouts on Thrombogenicity Directions to Hospitals Treating Thrombogenicity Risk calculators and risk factors for Thrombogenicity
|
Healthcare Provider Resources |
Causes & Risk Factors for Thrombogenicity |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Thrombogenicity refers to the tendency of a material in contact with the blood to produce a thrombus, or clot. It not only refers to fixed thrombi but also to emboli, thrombi which have become detached and travel through the bloodstream. Thrombogenicity can also encompass events such as the activation of immune pathways and the complement system. All materials are considered to be thrombogenic with the exception of the endothelial cells which line the vasculature. Certain medical implants appear non-thrombogenic due to high flow rates of blood past the implant, but in reality all are thrombogenic to a degree.
A thrombogenic implant will eventually be covered by a fibrous capsule, the thickness of this capsule can be considered one measure of thrombogenicity, and if extreme can lead to the failure of the implant.